New device for continuous eye pressure monitoring
Official title: Novel Approach to 24-hr IOP Assessment
Funded at University of California, San Francisco · NIH-11050775 · Data updated 2026-11-12
This study is working on a new smart contact lens that can keep track of eye pressure all day and night to help people with glaucoma manage their condition better and avoid any mismanagement.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | March 1, 2025 |
| Project end | February 28, 2030 |
| Funding year | 2025 |
| Award (this year) | $713,964 |
| NIH project number | 1R01EY036103-01A1 |
| Project ID | NIH-11050775 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with glaucoma or those at risk of developing the condition.
✕Less likely to help
Patients with other eye conditions unrelated to intraocular pressure may not benefit from this research.
What this research studies
This research focuses on developing a wearable device that can continuously monitor intraocular pressure (IOP) over a 24-hour period, which is crucial for managing glaucoma. Current devices have significant inaccuracies and do not capture IOP during sleep, leading to potential mismanagement of the condition. The project aims to create a non-invasive, automated contact lens-based sensor that accurately measures IOP fluctuations, helping to understand their impact on glaucoma progression. By utilizing advanced technology, the research seeks to improve the accuracy of glaucoma diagnosis and treatment monitoring.
Why it matters
Potential benefit: If successful, this research could lead to better management of glaucoma, reducing the risk of irreversible blindness for patients.
How similar studies have gone: Previous research has shown promise in developing wearable health monitoring devices, indicating potential success for this novel approach.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Knight, O'rese J — University of California, San Francisco
- Study coordinator: Knight, O'rese J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.